PuraPharm Corporation Limited (01498) announced the allotment and issue of new ordinary shares as of 30 October 2025. The company issued 93,488,372 consideration shares at HKD0.43 per share pursuant to a Patent Licence Agreement dated 25 July 2025, representing approximately 23.61% of the previously issued shares. An additional 46,512,000 subscription shares were allotted and issued at HKD0.43 per share under a Subscription Agreement dated 25 July 2025, accounting for around 11.75% of the previous share capital.

Following these issuances, the total number of issued shares increased from 395,897,275 to 535,897,647. The company confirmed that all procedures and conditions related to the new share allotments have been duly completed in accordance with applicable listing laws and regulations.